It activated the intracellular signal transduction mechanism related to NF-κB and the cell surface receptor TLR4, and further upregulated the downstream pro-inflammatory factors, culminating in the aggravation of cancer inflammation [56]. The gene discussed is CD177; the disease is cancer.